Known for its ancestry DNA tests, the Silicon Valley firm 23andMe Inc.
has licensed an antibody developed by them, to a Spanish drugmaker,
Almirall, for the treatment of inflammatory diseases. This is the
first time 23andMe is licensing its own drug component and this deal
was announced by Almairall in a filing with Spanish regulators. […]
The post 23andMe Licenses Its Own Drug Compound To Almirall appeared
first on BioTecNika .
https://www.biotecnika.org/2020/01/23andme-licenses-its-own-drug-to-almirall-a-spanish-drugmaker/
Biotech News
No comments:
Post a Comment